Our bridging study experience

About

Richmond Pharmacology Ltd has successfully conducted in excess of 60 studies Japanese and ethnic bridging studies since 2001. Our study experience includes First-In-Japanese, Single-Dose, Single-Ascending Dose, Multiple Dose, Multiple-Ascending Dose and combined Single and Multiple Dose protocols. All these studies have required a different in-house period, a variety of study designs and different Japanese populations; all managed by your expert Richmond Pharmacology Japanese Study Team.

Our unique and successful approach to volunteer advertising and recruitment has ensured that we are able to recruit a variety of Japanese volunteer populations to meet your needs.

Examples of our Bridging Studies in Japanese subjects in the last 2 years

Study Drug

No. of Subjects

Study Type

No.of nights

Familial Hypercholesterolemia

104

Double blind

34 nights

General Anaesthesia

72

Open-label

3 nights + 1 outpatient

Sleep disorder

48

Double blind

17 nights + 2 outpatients

Atheroscleorsis

80

Double blind

3 nights x 9 outpatients

GERD

30

Double blind

3 nights x 2

Obesity

36

Double blind

4 nights + 3 outpatient x 2

Over active bladder
symdrome

20

Double blind

3 nights x 4

TypeII Diabetes

36

Double blind

3 nights x 4

Alzheimer's disease

48

Double blind

8 nights

Neuropathic Pain

32

Double blind

3 nights

Major Depressive Disorder

36

Open-label

17 nights + 5 outpatients